Taking people in United StatesNo phase
CirrhosisRx CDS System
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 2,106 people, planned
- Started
- 14 Jan 2025
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- CirrhosisRx CDS
- Record updated
- 5 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- All adult (age ≥ 18 years) patients who have cirrhosis identified based on 1+ chronic liver disease and 1+ cirrhosis (or its complications) International Classification of Diseases, Revision 10 diagnosis codes OR mention of cirrhosis or portal hypertension (or their complications) in clinical documentation admitted at our institution
Who cannot take part
- Children (age < 18 years)
- patients who do not meet the cirrhosis definition criteria as noted above
- ambulatory patients
Where in United States
- University of California San Francisco Medical CenterSan Francisco, United StatesContact: Jin Ge, MD, MBATaking people
About the trial
What the trial wants to find out
The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
The 2 groups in the trial
- CirrhosisRxTreatment being tested
Providers in this arm will have access to the CirrhosisRx CDS system, which aggregates and organizes clinical data, presents them in clinically relevant/intuitive fashion for cirrhosis care, and linked to order sets consistent with national guidelines.
Treatment: CirrhosisRx CDS
- Usual CareNo study treatment, for comparison
Providers in this arm will not have access to the CirrhosisRx CDS system.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pragmatic Randomized Controlled Trial to Evaluate the Effect of CirrhosisRx, a Novel Clinical Decision Support System, on Guideline-adherence and Clinical Outcomes for Patients With Cirrhosis
- Record updated
- 5 November 2026